To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP
Public ClinicalTrials.gov record NCT05581199. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study of Batoclimab Treatment in Adult Participants With Active Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Study identification
- NCT ID
- NCT05581199
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Immunovant Sciences GmbH
- Industry
- Enrollment
- 277 participants
Conditions and interventions
Interventions
- Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly Drug
- Batoclimab 340 mg SC weekly Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 14, 2022
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2026
- Last update posted
- Nov 24, 2024
2022 – 2027
United States locations
- U.S. sites
- 33
- U.S. states
- 17
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Number - 1603 | Scottsdale | Arizona | 85028 | — |
| Site Number - 1618 | Carlsbad | California | 92011 | — |
| Site Number - 1634 | Los Angeles | California | 90033-5330 | — |
| Site Number - 1619 | Orange | California | 92868 | — |
| Site Number - 1608 | San Francisco | California | 94109 | — |
| Site Number - 1625 | Aurora | Colorado | 80045 | — |
| Site Number - 1636 | Fort Collins | Colorado | 80528 | — |
| Site Number - 1621 | New Haven | Connecticut | 06519 | — |
| Site Number - 1630 | Washington D.C. | District of Columbia | 20010 | — |
| Site Number - 1600 | Boca Raton | Florida | 33487 | — |
| Site Number - 1609 | Jacksonville | Florida | 32224 | — |
| Site Number - 1631 | Orlando | Florida | 32804 | — |
| Site Number - 1629 | Orlando | Florida | 32806-5411 | — |
| Site Number - 1617 | Ormond Beach | Florida | 32174 | — |
| Site Number - 1620 | Port Charlotte | Florida | 33952 | — |
| Site Number - 1633 | Rockledge | Florida | 32955 | — |
| Site Number - 1604 | St. Petersburg | Florida | 33713 | — |
| Site Number - 1607 | O'Fallon | Illinois | 62269 | — |
| Site Number - 1602 | Kansas City | Kansas | 66160 | — |
| Site Number - 1611 | Nicholasville | Kentucky | 40356 | — |
| Site Number - 1622 | Brooklyn | New York | 11220 | — |
| Site Number - 1605 | New York | New York | 10032 | — |
| Site Number - 1635 | Chapel Hill | North Carolina | 27559 | — |
| Site Number - 1610 | Charlotte | North Carolina | 28207 | — |
| Site Number - 1614 | Portland | Oregon | 97239 | — |
| Site Number - 1623 | Philadelphia | Pennsylvania | 19104 | — |
| Site Number - 1624 | Philadelphia | Pennsylvania | 19104 | — |
| Site Number -1601 | Austin | Texas | 78759 | — |
| Site Number - 1606 | Houston | Texas | 77030 | — |
| Site Number - 1628 | San Antonio | Texas | 78229 | — |
| Site Number - 1627 | Richmond | Virginia | 23298 | — |
| Site Number - 1632 | Seattle | Washington | 98195-0001 | — |
| Site Number - 1613 | Milwaukee | Wisconsin | 53226-3548 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 83 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05581199, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 24, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05581199 live on ClinicalTrials.gov.